COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Liquidity Coverage Analysis including current ratio, quick ratio, cash ratio, interest coverage ratio, gross margin, operating margin, net margin, return on assets, return on equity, return on invested capital. Compare liquidity against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Liquidity & Coverage Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Highlights the firm's ability to meet near-term obligations and cover interest expenses. For conservative value investors, strong liquidity and coverage metrics are critical to avoid distress or forced dilution.

Current Ratio

0.83

Increased from previous period

Current Ratio 0.5–0.75x Medical - Pharmaceuticals median of 1.50. Guy Spier would worry about potential short-term pinch.

Quick Ratio

0.42

Increased from previous period

Quick Ratio below 0.5x Medical - Pharmaceuticals median of 1.18. Jim Chanos might see a liquidity gap if the firm cannot tap more credit swiftly.

Cash Ratio

0.35

Increased from previous period

Cash Ratio 1.25–1.5x Medical - Pharmaceuticals median of 0.31. Mohnish Pabrai might see the market undervaluing high immediate liquidity.

Interest Coverage Ratio

307.06

Increased from previous period

Interest coverage of 307.06 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our debt service capacity provides advantages.

Short-Term Coverage Ratio

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric:

3349.T Liquidity & Coverage Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Current Ratio

0.83

Increased from previous period

Current Ratio 0.5–0.75x Medical - Pharmaceuticals median of 1.50. Guy Spier would worry about potential short-term pinch.

Quick Ratio

0.42

Increased from previous period

Quick Ratio below 0.5x Medical - Pharmaceuticals median of 1.18. Jim Chanos might see a liquidity gap if the firm cannot tap more credit swiftly.

Cash Ratio

0.35

Increased from previous period

Cash Ratio 1.25–1.5x Medical - Pharmaceuticals median of 0.31. Mohnish Pabrai might see the market undervaluing high immediate liquidity.

Interest Coverage Ratio

307.06

Increased from previous period

Interest coverage of 307.06 versus zero Medical - Pharmaceuticals median. Walter Schloss would verify if our debt service capacity provides advantages.

Short-Term Coverage Ratio

No Data

No Data available this quarter, please select a different quarter.

Select Chart Metric: